Financials
- Market Capitalization 8.51 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 992 | ABVX Abivax SA - American Depositary Shares | 113.35 USD | -0.83% | -0.57% | -10.93% | +41.67% | 8.90 B USD | ||
| 1013 | IBRX ImmunityBio, Inc. - Common Stock | 8.05 USD | -4.17% | +4.82% | +7.48% | +244.02% | 8.53 B USD | ||
| 1023 | APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1040 | TGTX TG Therapeutics, Inc. - Common Stock | 53.93 USD | -3.21% | +1.39% | +0.88% | +83.62% | 8.26 B USD |